Recent News

• 03.11.2025 - Leerink's Global Biopharma Conference 2025
• 03.06.2025 - Centessa Pharmaceuticals Announces Poster Presentation of Phase 1 Clinical Data for ORX750, a novel orexin receptor 2 (OX2R) agonist, at the American Academy of Neurology (AAN) 2025 Annual Meeting
• 03.04.2025 - TD Cowen 45th Annual Health Care Conference
• 02.12.2025 - Oppenheimer 35th Annual Healthcare Life Sciences Conference
• 02.06.2025 - Guggenheim Securities SMID Cap Biotech Conference

Recent Filings

• 02.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.25.2025 - 144 Report of proposed sale of securities
• 02.21.2025 - 8-K Current report
• 02.20.2025 - 144 Report of proposed sale of securities
• 02.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.18.2025 - 144 Report of proposed sale of securities
• 02.14.2025 - 10-Q/A Quarterly report [Sections 13 or 15(d)]
• 02.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.10.2025 - 144 Report of proposed sale of securities